[Federal Register Volume 91, Number 94 (Friday, May 15, 2026)]
[Notices]
[Pages 27946-27954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-09718]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-6102-N]


Medicare, Medicaid, and Children's Health Insurance Programs: 
Announcement of Nationwide Temporary Moratorium on Enrollment of 
Hospices

AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the imposition of a 6-month nationwide 
moratorium on the Medicare enrollment of hospices.

DATES: This moratorium is effective on May 13, 2026.

FOR FURTHER INFORMATION CONTACT: Frank Whelan, (410) 786-1302.

SUPPLEMENTARY INFORMATION:

I. Background

A. CMS' Authority To Impose Temporary Enrollment Moratoria

1. Statutory and Regulatory Background
    Under the Patient Protection and Affordable Care Act (Pub. L. 111-
148), as amended by the Health Care and Education Reconciliation Act of 
2010 (Pub. L. 111-152) (collectively known as the Affordable Care Act), 
Congress provided the Secretary with new tools and resources to combat 
fraud, waste, and abuse in Medicare, Medicaid, and the Children's 
Health Insurance Program (CHIP). One of these was section 6401(a) of 
the Affordable Care Act, which added a new section 1866(j)(7) to the 
Social Security Act (the Act). It provided the Secretary with authority 
to impose a temporary moratorium on the enrollment of new fee-for-
service (FFS) Medicare, Medicaid or CHIP providers and suppliers 
(including categories of providers and suppliers) if the Secretary 
determines that a moratorium is necessary to prevent or combat fraud, 
waste, or abuse under these programs.
    Section 6401(b) of the Affordable Care Act added specific 
moratorium language applicable to Medicaid at section 1902(kk)(4) of 
the Act, requiring States to comply with any moratorium imposed by the 
Secretary unless the state determines that the imposition of such 
moratorium would adversely impact Medicaid beneficiaries' access to 
care. Section 6401(c) of the Affordable Care Act amended section 
2107(e)(1) of the Act to provide that all the Medicaid provisions in 
sections 1902(a)(77) and 1902(kk) also apply to CHIP.
    In February 2011, in accordance with the aforementioned authority, 
CMS published a final rule with comment period titled, ``Medicare, 
Medicaid, and Children's Health Insurance Programs; Additional 
Screening Requirements, Application Fees, Temporary Enrollment 
Moratoria, Payment Suspensions and Compliance Plans for Providers and 
Suppliers'' (76 FR 5862). This final rule implemented section 
1866(j)(7) of the Act by establishing new regulations at 42 CFR 
424.570. Under Sec.  424.570(a)(2)(i) and (iv), CMS--or CMS in 
consultation with the Department of Health and Human Services Office of 
Inspector General (HHS-OIG), the Department of Justice (DOJ), or both--
may impose a temporary moratorium on newly enrolling Medicare providers 
and suppliers if CMS determines that there is a significant potential 
for fraud, waste, or abuse with respect to a particular provider or 
supplier type, particular geographic areas, or both.
2. Particulars of a Moratorium as Outlined in Sec.  424.570
a. Length
    Per Sec.  424.570(b), a temporary enrollment moratorium imposed by 
CMS remains in effect for 6 months. If CMS deems it necessary, the 
moratorium may be extended in 6-month increments. CMS evaluates whether 
to extend or lift the moratorium before the end of the initial 6-month 
period and, if applicable, before the expiration of any subsequent 
moratorium period. If the moratorium announced in this notice is 
extended, CMS will publish a document regarding such extension(s) in 
the Federal Register.
b. Cessation
    As provided in Sec.  424.570(d), CMS may lift a moratorium at any 
time if: (1) the President declares an area a disaster under the Robert 
T. Stafford Disaster Relief and Emergency Assistance Act; (2) 
circumstances warranting the imposition of a moratorium have abated or 
CMS has implemented program safeguards to address the program 
vulnerability; (3) the Secretary has declared a public health 
emergency; or (4) in the judgment of the Secretary, the moratorium is 
no longer needed. Once a moratorium is lifted, the provider or supplier 
types that were unable to enroll because of the moratorium will be 
assigned to the ``high'' screening level in accordance with Sec. Sec.  
424.518(c)(3)(iii) and 455.450(e)(2) if such provider or supplier 
applies for enrollment at any time within 6 months from the date the 
moratorium was lifted.
c. Circumstances in Which Moratorium Is Inapplicable
    Under Sec.  424.570(a)(1)(iii), a temporary moratorium does not 
apply to any of the following:
     Changes in practice location (except if the location is 
changing from a location outside the moratorium area to a location 
inside the moratorium area).
     Changes in provider or supplier information, such as phone 
numbers.
     Changes in ownership (except changes in ownership of home 
health agencies, hospices, or suppliers of durable medical equipment, 
prosthetics, orthotics, and supplies (DMEPOS) that would require an 
initial enrollment).
    Also, in accordance with Sec.  424.570(a)(1)(iv), a temporary 
moratorium does not apply to any enrollment application that has been 
received by the Medicare contractor prior to the date the moratorium is 
imposed.
3. Announcement of Moratorium
    CMS states at Sec.  424.570(a)(1)(ii) that it will announce a 
temporary moratorium in a Federal Register notice that includes the 
rationale for its imposition. This notice fulfills that requirement.

[[Page 27947]]

B. CMS' Previous Temporary Enrollment Moratoria

    We first used our moratorium authority in a notice issued on July 
31, 2013 (78 FR 46339). The moratorium prevented enrollment of: (1) new 
home health agencies (HHAs) in Miami-Dade County, Florida and Cook 
County, Illinois, as well as surrounding counties; and (2) Part B 
ambulance suppliers in Harris County, Texas and surrounding counties. 
We exercised our moratorium authority again in a notice published on 
February 4, 2014 (79 FR 6475). This involved--
     Extending our existing moratoria for an additional 6 
months.
     Expanding it to include enrollment of--
    ++ HHAs in Broward County, Florida; Dallas County, Texas; Harris 
County, Texas; and Wayne County, Michigan and surrounding counties; and
    ++ Ground ambulance suppliers in Philadelphia, Pennsylvania and 
surrounding counties.
    We extended these moratoria for additional 6-month periods on 
August 1, 2014 (79 FR 44702), February 2, 2015 (80 FR 5551), July 28, 
2015 (80 FR 44967), and February 2, 2016 (81 FR 5444).
    We again extended these moratoria for another 6 months on August 3, 
2016 (81 FR 51120) and also expanded them statewide with respect to the 
enrollment of new HHAs in Florida, Illinois, Michigan, and Texas, and 
Part B non-emergency ambulance suppliers in New Jersey, Pennsylvania, 
and Texas. Yet in this same notice, we announced the lifting of 
temporary moratoria for all Part B emergency ambulance suppliers.
    The original 2013 moratorium, after being extended and revised 
several times,\1\ expired on January 30, 2019. However, in the February 
27, 2026, Federal Register (91 FR 9855), we published a notice 
announcing a 6-month nationwide moratorium on medical supply companies 
enrolling as suppliers of DMEPOS.\2\ This moratorium remains in effect.
---------------------------------------------------------------------------

    \1\ On January 9, 2017, CMS issued another notice to extend the 
temporary moratoria for a period of 6 months (82 FR 2363). On 
January 9, 2017 (82 FR 2363) and July 28, 2017 (82 FR 35122), CMS 
again issued a notice to extend the temporary moratoria for a period 
of 6 months. On September 1, 2017, CMS lifted the Statewide 
temporary moratorium on the enrollment of new Medicare Part B non-
emergency ground ambulance suppliers in Texas under the authority of 
Sec.  424.570(d). This lifting of the moratorium also applied to 
Medicaid and CHIP in Texas. This decision was a result of the 
Presidential Disaster Declaration signed on August 25, 2017, for 
several counties in the State of Texas due to Hurricane Harvey. Upon 
declaration of the disaster, CMS carefully reviewed the potential 
impact of continued moratoria in Texas and decided to lift the 
temporary enrollment moratorium on non-emergency ground ambulance 
suppliers in Texas in order to aid in the disaster response. CMS 
published a formal announcement of this decision on November 3, 2017 
(82 FR 51274). On January 30, 2018 (83 FR 4147), CMS announced the 
extension of the temporary moratoria for an additional 6 months. In 
August 2018, CMS announced the extension of the temporary moratoria 
for an additional 6 months. CMS allowed the temporary moratoria to 
expire on January 30, 2019.
    \2\ ``Medicare, Medicaid, and Children's Health Insurance 
Programs: Announcement of Nationwide Temporary Moratoria on 
Enrollment of Durable Medical Equipment, Prosthetics, Orthotics, and 
Supplies (DMEPOS) Supplier Medical Supply Companies'', 91 FR 9855.
---------------------------------------------------------------------------

C. Determination of the Need for Moratoria

    In determining whether to establish an enrollment moratorium, CMS 
considers whether a high risk of fraud, waste, or abuse exists. CMS 
also relies on its own and law enforcement's longstanding experience 
with ongoing and emerging fraud trends and activities gained through 
civil, criminal, and administrative investigations and prosecutions.
1. Law Enforcement
    The HHS-OIG has highlighted the problem of hospice fraud, waste, 
and abuse. It recently stated: ``[T]here are significant problems with 
the (hospice) program. Our reports and investigations have revealed 
several concerning issues, including poor--sometimes harmful--quality 
of care, fraud schemes that involve enrolling beneficiaries without 
their consent, inappropriate billing practices, limited transparency 
for patients and their families, a payment system that creates 
incentives to minimize services, and a rapid growth in the number of 
new hospices, often to take advantage of these conditions.'' \3\ The 
OIG in April 2025 also announced an upcoming audit titled ``Trends, 
Patterns, and Key Comparisons Related to New Medicare Hospice Provider 
Enrollments May Indicate the Need for Further Oversight'' (OAS-25-09-
034), stating: ``Our objective is to identify trends, patterns, and key 
comparisons that indicate potential vulnerabilities related to new 
Medicare hospice provider enrollments. The data brief may help CMS 
evaluate the need for additional monitoring and program integrity 
efforts to ensure that hospices meet all the requirements.'' \4\
---------------------------------------------------------------------------

    \3\ https://oig.hhs.gov/reports/featured/hospice/.
    \4\ https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/trends-and-patterns-in-data-related-to-newly-enrolled-hospice-providers/.
---------------------------------------------------------------------------

    The OIG and DOJ have in the past encouraged CMS to undertake anti-
fraud measures regarding hospices, and we believe the action announced 
by this notice is consistent therewith.
2. Data Analysis
    In contemplating the present moratorium, we also used data analysis 
that included reviewing (i) both current and historic Medicare 
enrollment data and (ii) indicators of fraud, waste, and abuse. 
Sections II.A. and B. of this notice discuss our review in more detail.
3. Beneficiary Access to Care
    Patient access to care in Medicare, Medicaid and CHIP is of 
critical importance to CMS and our state partners. CMS has carefully 
evaluated access to hospice care for Medicare beneficiaries nationwide. 
We discuss our findings later in this notice.

II. National Hospice Moratorium

    Per our authority at Sec.  424.570(a)(2)(i) and (a)(2)(iv), CMS is 
implementing a nationwide temporary moratorium on the Medicare 
enrollment of hospices. In this section of this notice, we explain the 
rationale for and scope of this moratorium.

A. Hospice Program Integrity Risks

1. The Increased Threat of Hospice Fraud, Waste, and Abuse
    As previously indicated, hospice fraud, waste, and abuse has been a 
dilemma for some time. Although, on the surface, hospices traditionally 
had not appeared to pose the program integrity threat of certain other 
provider/supplier types like HHAs and DMEPOS suppliers, the elevated 
risk was still there. This risk has dramatically increased in the past 
7 years to the point where hospices present no less of a payment 
safeguard threat than HHAs and DMEPOS suppliers. CMS outlined the 
rising problems in 2023, noting in part the following:
     Instances of hospices certifying patients for hospice care 
when they were not terminally ill and providing little to no services 
to beneficiaries.\5\ This included telling patients that they were 
terminally ill when they were not. In such circumstances, beneficiaries 
who are inappropriately deemed terminally ill may be denied coverage 
for other care because they are receiving the hospice benefit.
---------------------------------------------------------------------------

    \5\ https://www.cms.gov/blog/cms-taking-action-address-benefit-
integrity-issues-related-hospice-
care#:~:text=Unfortunately%2C%20hospices%20are%20profiting%20from,ben
eficiaries%20in%20the%20Medicare%20program.
---------------------------------------------------------------------------

     The rapid growth in potentially fraudulent hospices, 
particularly in

[[Page 27948]]

Arizona, California, Nevada, and Texas, and that some of the addresses 
for these hospices appeared to be non-operational.\6\
---------------------------------------------------------------------------

    \6\ Ibid.
---------------------------------------------------------------------------

     ``Churn and burn'' schemes whereby a new hospice opens and 
starts billing but once that hospice is audited or reaches its 
statutory yearly payment limit, it shuts down, keeps the money, and 
buys a new Medicare billing number; it then transfers its patients over 
to the new Medicare billing number, and starts billing again.\7\
---------------------------------------------------------------------------

    \7\ Ibid.
---------------------------------------------------------------------------

    Other problems we have seen included but were not limited to: (1) 
hospices paying recruiters to target beneficiaries who are not eligible 
for hospice care, sometimes without the beneficiary's knowledge; (2) 
hospices paying kickbacks to physicians for the latter to falsely 
certify a patient's terminal status (or falsely certifying even without 
receiving renumeration); and (3) parties establishing hospices for the 
exclusive purpose of selling them for a profit and/or after committing 
fraud but before they can be revoked from Medicare. Furnishing quality 
patient care was not a priority--or even a consideration--for these 
parties.
    The tremendous growth in the number of hospices in certain states 
has been especially noteworthy and disturbing. In Arizona, California, 
Nevada, and Texas, the percentage increase has been far higher than 
that of hospice beneficiaries. Consider the following CMS data between 
calendar year (CY) 2019 and 2023:

                           Table 1--Number of Enrolled Hospices in CY 2019 and CY 2023
----------------------------------------------------------------------------------------------------------------
                                                                                                    Percentage
                              State                                   CY 2019         CY 2023        increase
----------------------------------------------------------------------------------------------------------------
Arizona.........................................................             152             311             105
California......................................................           1,130           2,559             126
Nevada..........................................................              55             138             151
Texas...........................................................             718           1,081              51
----------------------------------------------------------------------------------------------------------------

    The problem has been particularly acute in places like Los Angeles 
County in California, where numerous hospices were simultaneously 
operating out of a single building or otherwise were massed in large 
numbers within a very small geographic area or neighborhood.
2. Criminal and Other Improper Hospice Activity
    In the CY 2024 Home Health Prospective Payment System (HH PPS) 
final rule (88 FR 77676) and the Fiscal Year (FY) 2024 Hospice Wage 
Index final rule (88 FR 51164), we outlined a number of improper 
hospice activities we had seen.\8\ This included criminal cases 
involving hospices. We unfortunately continue to see criminal or other 
inappropriate activity in the hospice sphere, with some court cases 
involving the behavior cited in section II.A. of this notice. Recent 
cases include, but are not limited to, the following:
---------------------------------------------------------------------------

    \8\ ``Medicare Program; Calendar Year (CY) 2024 Home Health (HH) 
Prospective Payment System Rate Update; HH Quality Reporting Program 
Requirements; HH Value-Based Purchasing Expanded Model Requirements; 
Home Intravenous Immune Globulin Items and Services; Hospice 
Informal Dispute Resolution and Special Focus Program Requirements, 
Certain Requirements for Durable Medical Equipment Prosthetics and 
Orthotics Supplies; and Provider and Supplier Enrollment 
Requirements'', November 13, 2023 (88 FR 77676); ``Medicare Program; 
FY 2024 Hospice Wage Index and Payment Rate Update, Hospice 
Conditions of Participation Updates, Hospice Quality Reporting 
Program Requirements, and Hospice Certifying Physician Provider 
Enrollment Requirements'', August 2, 2023 (88 FR 51164).
---------------------------------------------------------------------------

     A former Louisiana resident in June 2024 was sentenced to 
6 years in prison for conspiracy to commit health care fraud and three 
counts of health care fraud. Evidence presented at trial demonstrated 
that over 24 patients were placed on hospice by the defendant's hospice 
without meeting the criteria required by Medicare. During the time 
period that the patients were under the care and supervision of the 
hospice, none of them had been diagnosed with a terminal condition and, 
in fact, many of the patients and their families never even knew they 
had been placed on hospice. One patient testified at trial that 
Medicare refused to cover a procedure he needed to have because, 
unbeknownst to him, he was listed as a hospice patient. Many of these 
patients thought they were receiving some type of home health or free 
services, rather than being placed on hospice.\9\
---------------------------------------------------------------------------

    \9\ https://www.justice.gov/usao-wdla/pr/hospice-care-company-owner-sentenced-health-care-fraud-charges.
---------------------------------------------------------------------------

     A Utah health care company in March 2023 agreed to pay 
over $1 million to resolve allegations they violated the False Claims 
Act by submitting false claims to Medicare and Medicaid for hospice 
services that were not medically necessary; the patients' records 
lacked documentation of a terminal illness to qualify for services.\10\
---------------------------------------------------------------------------

    \10\ https://www.justice.gov/usao-ut/pr/summit-hospice-pay-over-1m-settle-false-claims-liability.
---------------------------------------------------------------------------

     Several California residents were sentenced to prison in 
2025 for their roles in defrauding Medicare of nearly $16 million 
through sham hospice companies and laundering the fraudulent proceeds. 
According to court documents, the individuals--who operated several 
sham hospices--schemed to bill Medicare for hospice services that were 
medically unnecessary and never provided. They concealed the scheme by 
using foreign nationals' names and personally identifiable information 
to act as straw owners for the hospices and to open bank accounts, 
submit information to Medicare, and sign property leases. They also 
controlled and used cell phones in the names of the foreign nationals 
in furtherance of the scheme. After defrauding Medicare, the 
individuals moved the funds between various assets and accounts--
including bank accounts in the names of shell companies--to further 
conceal their actions.\11\
---------------------------------------------------------------------------

    \11\ https://www.justice.gov/opa/pr/four-california-residents-sentenced-prison-connection-16m-hospice-fraud-and-money-laundering.
---------------------------------------------------------------------------

     Two California residents were found guilty in December 
2024 of paying and receiving hundreds of thousands of dollars in 
illegal kickbacks for patient referrals that resulted in the submission 
of approximately $3.2 million in fraudulent claims to Medicare for 
purported hospice care. One of the individuals had been excluded from 
Medicare because of prior federal convictions for receiving illegal 
kickbacks. While excluded, she purchased a hospice through her daughter 
and concealed her ownership interest in the hospice from Medicare. She 
(the owner) then paid ``marketers'' (including her co-defendant) 
hundreds of thousands of dollars in illegal kickbacks for patient 
referrals that she could bill to Medicare for purported hospice care.
    Also, and consistent with the owner's instructions, the co-
defendant falsely

[[Page 27949]]

represented to prospective patients that they did not need to be dying 
to be on hospice. After collecting personal identifying information 
from prospective patients who were not dying, the co-defendant sent the 
information to the owner so the latter could bill Medicare for 
purported hospice care. Many of the patients that were billed to the 
hospice did not know they were signed up for hospice, and some patients 
only found out after they were denied medical coverage for services 
they needed. In addition:
    ++ When Medicare requested additional documentation from the 
hospice to support the purported hospice claims, the owner and her 
husband directed employees to create fake patient charts and had said 
charts submitted to Medicare.
    ++ Court documents alleged that while awaiting trial in this 
matter, the owner took control of three other hospices and caused the 
submission of approximately $4.8 million in claims for purported 
hospice care.\12\
---------------------------------------------------------------------------

    \12\ https://www.justice.gov/usao-cdca/pr/glendale-woman-and-lakewood-man-found-guilty-32-million-hospice-fraud-scheme-involving.
---------------------------------------------------------------------------

     A successor to a hospice chain agreed in July 2024 to pay 
over $19 million to resolve allegations that the chain knowingly 
submitted false claims and knowingly retained overpayments for hospice 
services provided to patients who were ineligible to receive hospice 
benefits. The hospice locations included sites in Rhode Island, Texas, 
Missouri, Alabama, Indiana, and Ohio. The specific allegations included 
the following:
    ++ The defendants knowingly submitted or caused to be submitted 
false claims for hospice services provided to hospice patients who were 
ineligible for the Medicare or Medicaid hospice benefit because they 
were not terminally ill.
    ++ Some locations knowingly and improperly concealed or avoided 
obligations to repay the foregoing hospice claims.
    ++ One location allegedly violated the Anti-Kickback Statute by 
willfully paying renumeration to a consulting physician to induce 
hospice referrals.\13\
---------------------------------------------------------------------------

    \13\ https://www.justice.gov/usao-wdky/pr/kindred-and-related-entities-agree-pay-19428m-settle-federal-and-state-false-claims.
---------------------------------------------------------------------------

     A Georgia hospice and its owners and managers in June 2024 
agreed to pay $1.4 million to resolve allegations that they violated 
the False Claims Act by entering into kickback arrangements with 
medical directors in exchange for referrals of hospice patients to the 
hospice. The alleged kickbacks included monthly stipends and a signing 
bonus paid to the medical directors. The compensation allegedly 
increased when the medical director referred more patients and 
decreased when the medical director failed to make referrals. The 
Special Agent in Charge of the Federal Bureau of Investigation's 
Atlanta office stated: ``The False Claims Act settlement in this case 
will hopefully be a deterrent to those who selfishly evade our federal 
healthcare programs for their own benefit.'' The Georgia Attorney 
General added: ``Decisions regarding end-of-life care are incredibly 
difficult and personal, and families must be able to trust the 
intentions of their chosen providers. Those who instead take advantage 
of the system for their own personal gain will be held accountable.'' 
\14\
---------------------------------------------------------------------------

    \14\ https://www.justice.gov/usao-ndga/pr/tapestry-hospice-settles-healthcare-kickback-claims-14-million.
---------------------------------------------------------------------------

     The owner and operator of a Louisiana hospice with 
multiple offices was sentenced to 20 years in prison in May 2024 for 
orchestrating an extensive health care fraud scheme. The hospice billed 
Medicare approximately $84 million in fraudulent claims and was paid 
approximately $42 million relating to these claims. The scheme 
involved: (1) overbilling for hospice patients for expensive general 
inpatient services; and (2) manipulating Medicare billing codes despite 
such services being medically unnecessary or despite their inclusion in 
the daily hospice benefit the hospice already received for its 
patients. The Special Agent in Charge at HHS-OIG said the defendant, 
``showed no regard for quality end-of-life hospice care. Instead, [his] 
motivation centered around multiple fraud schemes to maximize profit 
and steal from American taxpayers.'' The Special Agent in Charge of the 
FBI New Orleans Division stated: ``Each fraudulent claim filed by [the 
defendant] potentially deprived another deserving and suffering 
individual from the emotional and physical comfort of end-of-life 
care.'' \15\
---------------------------------------------------------------------------

    \15\ https://www.justice.gov/usao-edla/pr/hospice-owner-sentenced-240-months-imprisonment-and-ordered-repay-42000000-defrauding.
---------------------------------------------------------------------------

     Several companies in May 2024 agreed to pay $4.2 million 
to resolve allegations that they violated the False Claims Act by 
knowingly submitting false claims and knowingly retaining overpayments 
for the care of hospice patients in Texas; the patients were ineligible 
for the Medicare hospice benefit because they were not terminally 
ill.\16\
---------------------------------------------------------------------------

    \16\ https://www.justice.gov/archives/opa/pr/elara-caring-agrees-pay-42-million-settle-false-claims-act-allegations-it-billed-medicare.
---------------------------------------------------------------------------

     The owner of two California-based hospice companies, along 
with his biller/consultant, were sentenced to prison in March 2024 for 
their roles in a scheme that resulted in obtaining over $9 million from 
Medicare in false and fraudulent claims for hospice services. According 
to court documents, the owner concealed his ownership and control over 
the hospice entities from Medicare, inserted nominee owners, paid 
kickbacks to patient recruiters, and profited from the scheme. The 
biller/consultant, meanwhile, submitted false and fraudulent Medicare 
enrollment forms, falsely identifying a straw owner as the sole owner 
and manager and concealing the actual owners and managers.\17\
---------------------------------------------------------------------------

    \17\ https://www.justice.gov/archives/opa/pr/two-men-sentenced-role-9m-hospice-fraud-scheme.
---------------------------------------------------------------------------

     In February 2024, a California man was convicted for his 
role in a scheme to defraud Medicare by billing $2.8 million for 
hospice services that patients did not need. According to court 
documents and evidence presented at trial, the individual was the 
medical director of several hospice companies. He fraudulently 
certified Medicare patients of one hospice as having terminal illnesses 
that the patients did not have so the hospice could bill Medicare for 
hospice services. The individual in 2015 was listed as the attending 
provider for more hospice claims paid by Medicare than any other 
provider in the nation.\18\
---------------------------------------------------------------------------

    \18\ https://www.justice.gov/archives/opa/pr/doctor-convicted-28m-medicare-fraud-scheme.
---------------------------------------------------------------------------

     A Texas man in September 2023 was sentenced to prison for 
his role in a scheme that involved the submission of over $150 million 
in false and fraudulent claims to Medicare for hospice and other health 
care services. According to court documents, the person was the medical 
director of a large health care company that operated dozens of 
locations throughout Texas. Evidence at the trial of his co-defendants 
showed that the company marketed their hospice programs through a group 
of companies. They enrolled patients with long-term incurable diseases, 
such as Alzheimer's and dementia, as well as patients with limited 
mental capacity who lived at group homes, nursing homes, and in housing 
projects. In some instances, the company marketers falsely told 
patients they had less than six months to live. They also sent 
chaplains to the patients based on the false pretense they were near 
death. The group hired the defendant and other medical directors but 
made payment of their medical director fees contingent upon an

[[Page 27950]]

agreement to certify unqualified patients for hospice. In addition to 
regular medical director payments, the defendant received luxury trips, 
bottle service at exclusive nightclubs, and other perks in exchange for 
his certification of unnecessary hospice patients. He himself certified 
over $18 million in unnecessary hospice services as part of the over 
$150 million conspiracy.\19\
---------------------------------------------------------------------------

    \19\ https://www.justice.gov/archives/opa/pr/hospice-medical-director-sentenced-150m-hospice-fraud-scheme.
---------------------------------------------------------------------------

     An Oklahoma hospice company agreed to pay over $48,000 to 
resolve allegations that it violated the False Claims Act by knowingly 
submitting false claims to Medicare for hospice care provided to 
beneficiaries who did not qualify for the services (they were not 
terminally ill) and for services that were not medically necessary.\20\
---------------------------------------------------------------------------

    \20\ https://www.justice.gov/usao-ndok/pr/united-states-settles-false-claims-allegations-against-evergreen-hospice-llc-48830.
---------------------------------------------------------------------------

     A health care company in February 2025 agreed to pay $3 
million to resolve allegations that it violated the False Claims Act by 
knowingly submitting false claims for the care of hospice patients in 
Alabama who were ineligible for the Medicare hospice benefit because 
they were not terminally ill.\21\
---------------------------------------------------------------------------

    \21\ https://www.justice.gov/opa/pr/saad-healthcare-agrees-pay-3m-settle-false-claims-act-allegations-it-billed-medicare.
---------------------------------------------------------------------------

     A California physician who worked for two hospices was 
sentenced to Federal prison in December 2024. He and his co-defendant 
schemed to defraud Medicare by submitting nearly $4 million in false 
and fraudulent claims for hospice services submitted by two hospice 
companies, which the co-defendant controlled. The physician falsely 
stated on claim forms that patients had terminal illnesses to make them 
eligible for hospice services covered by Medicare, typically adopting 
diagnoses provided to him by hospice employees whether or not they were 
true. He did so even though he was not the patients' primary care 
physician and had not spoken to those primary care physicians about the 
patients' conditions. Medicare paid on the claims supported by the 
defendant's false evaluations and certifications and recertifications 
of patients.\22\
---------------------------------------------------------------------------

    \22\ https://www.justice.gov/usao-cdca/pr/santa-paula-doctor-sentenced-2-years-federal-prison-role-hospice-fraud-bilked-medicare.
---------------------------------------------------------------------------

3. CMS Measures Regarding Hospice Fraud
    To address several of the foregoing issues, CMS has taken a number 
of regulatory and operational initiatives.
    First, all providers/suppliers are assigned to an application 
screening level under Sec.  424.518 of ``limited,'' ``moderate,'' or 
``high.'' Those in the ``high'' category receive the strictest 
scrutiny. When initially enrolling in Medicare or undergoing an 
ownership change ``high'' level providers/suppliers must undergo a site 
visit and have their 5 percent or greater owners be subject to 
fingerprinting for a criminal background check. Hospices in 2011 were 
originally assigned to the ``moderate'' category. Given the increase in 
hospice fraud, waste, abuse--which includes the consequent need to 
exercise closer scrutiny of hospice owners, such as through criminal 
background reviews--we moved hospices to the ``high'' classification 
beginning in 2024. Hospices are one of only six provider/supplier types 
in the ``high'' category, which reflects their uniquely elevated risk.
    Second, and to further increase our oversight of hospices, we 
expanded the change in majority ownership (CIMO) ``36-month rule'' in 
Sec.  424.550(b) to include hospices. We found in the mid-2000s that 
some HHAs were attempting to enter Medicare without undergoing the 
required State survey or accreditation. Brokers would enroll an HHA 
(after being surveyed or accredited) with the specific intention of 
quickly selling it--or ``flipping'' it--to another party. This enabled 
the buyer to participate in Medicare with no survey or accreditation of 
the HHA under its new ownership--hence increasing the possibility of an 
illegitimate HHA furnishing (and billing for) poor or otherwise non-
compliant services to beneficiaries. We thus promulgated Sec.  424.550 
in 2009, which required an HHA undergoing a CIMO within 36 months of 
its initial enrollment (or within 36 months of its most recent CIMO) to 
initially enroll as a new HHA and undergo a State survey or 
accreditation (unless certain exceptions apply). As already noted, we 
have seen similar situations in the hospice realm, whereby promptly 
selling the business--rather than furnishing good patient care--is the 
hospice's owner's principal motivation. We believed that expanding the 
36-month rule to hospices would help stem the practice by, in part, 
facilitating a thorough vetting of the new owner and the hospice in 
question via a survey or accreditation.
    Third, 42 CFR 418.22(c) states that (1) the hospice medical 
director, the physician designee (as defined in Sec.  418.3), or the 
physician member of the hospice interdisciplinary group (hereafter the 
``hospice physician'') and (2) the attending physician (if the 
beneficiary has one) must initially certify the patient's terminal 
condition. (For subsequent periods, only the hospice physician must do 
so). We revised 42 CFR 424.507 in 2023 to require these two categories 
of physicians to be enrolled in or opted-out of Medicare in order for 
the hospice service to be paid. We concluded that requiring enrollment 
or opt-out would allow us to screen the certifying physician to ensure 
they are qualified (for example, licensed) to certify the terminal 
condition and do not pose program integrity risks such as past final 
adverse actions (as that term is defined in Sec.  424.502). This is a 
particularly important consideration given the aforementioned issue of 
improper certifications.
    Fourth, section 1866(j)(3) of the Act permits the Secretary to 
establish a provisional period of enhanced oversight (PPEO) of between 
30 days and 1 year during which new providers or suppliers (including 
categories thereof) would be subject to enhanced oversight, such as 
prepayment review and payment caps. Consistent therewith, and in light 
of the payment safeguard threats that hospices posed, we implemented a 
PPEO in 2023 on new hospices enrolling in Arizona, California, Nevada, 
and Texas. Under this initiative, as of June 2025 approximately 670 
hospices were subject to medical review with 122 of them revoked from 
Medicare. This 18 percent revocation rate is far more than the average 
revocation rate of about 1 to 3 percent. (That is--and though it varies 
depending on, for example, the provider/supplier type in question and 
the geographic region involved--1 to 3 percent of providers/suppliers 
are revoked at least once during their enrollment). The much higher 
percentage of hospices revoked during this initiative compared to 
general provider/supplier revocation rates helps demonstrate the extent 
of the hospice program integrity problem.
    Fifth, we revised our provider enrollment regulations to clarify 
that hospice medical directors and administrators qualify as ``managing 
employees'' under Sec.  424.502. They must therefore be reported on the 
hospice's Form CMS-855A application (Medicare Enrollment Application--
Institutional Providers; OMB Control No. 0938-0685). This would foster 
greater transparency regarding the operators of hospices. It would also 
permit us to ascertain whether certain medical directors and 
administrators hold such roles at multiple hospices, which could be an 
indicator of a broader scheme if

[[Page 27951]]

the hospices in question otherwise pose program integrity risks.
    It should be noted, some of these initiatives mirrored 
recommendations made by national hospice organizations that expressed 
deep concerns about fraud within the hospice community--concerns that 
various members of Congress share.\23\
---------------------------------------------------------------------------

    \23\ Letter from United States House Representatives Brett 
Guthrie, John Joyce, M.D., Morgan Griffith, Jason Smith, David 
Schweikert, and Vern Buchanan to T. March Bell, Inspector General, 
HHS-OIG, January 9, 2026, https://energycommerce.house.gov/posts/chairmen-guthrie-joyce-griffith-smith-schweikert-and-buchanan-ask-hhs-oig-about-ongoing-hha-and-hospice-fraud-in-los-angeles-county-1; 
Letter from LeadingAge and the National Alliance for Care at Home 
Letter to Dr. Mehmet Oz, CMS Administrator, December 22, 2025, 
https://allianceforcareathome.org/wp-content/uploads/Final-Alliance-and-LeadingAge-Home-Health-and-Hospice-Program-Integrity-Recommendations.pdf.
---------------------------------------------------------------------------

B. Ongoing Problems in the Hospice Arena

1. Background and Need for Action
    CMS is aggressively continuing its efforts to crush hospice fraud, 
waste, and abuse via the previous and other measures. Closer 
examination of hospices via the ``36-month rule'' and the elevation of 
hospices to the ``high'' risk category may well have resulted in some 
problematic hospice owners being unable to enter Medicare. CMS' PPEO 
measures have, as stated, resulted in a number of revocations. Yet we 
are concerned that vulnerabilities remain. Notwithstanding our tighter 
screening, hospices can still enroll in large numbers if all Medicare 
requirements are initially met. This is precisely what occurred in Los 
Angeles County and elsewhere. The dilemma is that some of these 
providers later engaged in fraudulent activity. Put otherwise, we have 
indeed established more stringent requirements for hospices to 
initially enroll, but they cannot in every case prevent a potentially 
problematic hospice from entering Medicare. Hospice anti-fraud measures 
require a comprehensive, wide-ranging approach that impact a variety of 
hospice activities. They cannot be limited to post-enrollment scrutiny 
(such as medical review), greater screening of new owners, or even 
both. All facets of hospice enrollment must likewise be addressed. 
Given the continued severity of hospice program integrity problems, we 
believe that addressing the very front end of the enrollment process--
before the Medicare contractor even starts reviewing the hospice's 
initial enrollment application, screening the hospice's owners, etc.--
is a program integrity gap that must be filled. Preventive action--
specifically, halting fraud before it has a chance to begin--is a far 
better anti-fraud approach than the traditional ``pay-and-chase'' model 
of waiting for the fraud to happen before taking remedial steps.
2. The Historical Benefits of an Enrollment Moratorium
    Our previously mentioned HHA and ground ambulance moratoria were 
intended to address fraud, waste, and abuse among these two provider/
supplier types in general and, in particular, the rapid increase in the 
number of HHAs and ground ambulance suppliers in the affected 
localities. The two concepts are related. A sudden rise in new 
enrollments within a particular area that is not tied to a similar 
increase in the number of Medicare beneficiaries has long been a strong 
indicator of fraud, waste, and abuse. Consider Nevada in Table 1 of 
this notice. There was no medical justification for a 151 percent 
increase in enrolled hospices over a 4-year period, especially since 
the State's beneficiary population increased by no more than 10 percent 
during that timeframe; likewise, having dozens of newly enrolled 
hospices within a fairly small area of Los Angeles County strongly 
suggests improper behavior.
    The previous moratoria were, in our view, successful in stemming 
similar activity regarding HHAs and ground ambulance suppliers. Since 
there were no new enrollments of these provider/supplier types in the 
impacted high-fraud regions, new providers/suppliers that would or 
might otherwise have engaged in fraud, waste, and abuse in these areas 
were blocked from doing so. Too, with no new provider/suppliers coming 
in, we were able focus our program integrity efforts and resources on 
post-enrollment activities--that is, on enrolled HHAs and ground 
ambulance suppliers. Through our very close scrutiny of their 
activities and, in some cases, revocations, the overall number of 
enrolled HHAs and ground ambulance suppliers in said localities fell to 
a level more commensurate with the number of beneficiaries therein--and 
with this, an ostensible reduction in fraud, waste, and abuse.
    With the aforementioned program integrity gap at the beginning of 
the hospice enrollment process, the ongoing hospice payment safeguard 
issues, and the success of our previous moratoria, we believe that 
temporarily closing the enrollment door at the very start via a 
moratorium is required.

C. Nationwide Application

    Aside from the need to halt hospice fraud at the beginning, there 
is another consideration behind our planned moratorium and why we 
believe it should be nationwide: the transitory nature of fraud 
schemes.
    The main impetus for the enrollment measures discussed in section 
II.A. of this notice were the problems seen in Arizona, California, 
Nevada, and Texas--mostly involving the quick, sharp increase in new 
enrollments (described in Table 1). Since CY 2023, the number of new 
enrollments in Arizona, California, and Texas have fallen 
substantially, as shown in Table 2:

   Table 2--Number of Newly Enrolling Hospices in CY 2023 and CY 2025
------------------------------------------------------------------------
                  State                       CY 2023         CY 2025
------------------------------------------------------------------------
Arizona.................................              53               3
California..............................             362              29
Texas...................................             164              67
------------------------------------------------------------------------

    Encouraging though this is, difficulties remain--and are spreading. 
The number of newly enrolling hospices in Nevada has changed little 
since CY 2022 despite our hospice program integrity efforts. Whereas 
there were five new hospice enrollments in Nevada in CY 2019, between 
35 and 39 hospices have enrolled in each of the last 4 calendar years. 
The total number of enrolled Nevada hospices continues to rise at a 
rate well beyond that of the beneficiary population--from 138 in CY 
2023 to 188 in CY 2025, or 36 percent. This potentially reflects a 
shifting of some fraudulent hospice activity from California and 
Arizona to Nevada given the sharp decrease in new enrollments

[[Page 27952]]

in the former two States. Equally concerning is the increase in hospice 
payment safeguard problems in States like Ohio and Georgia, neither of 
which have historically been among the highest risk States for Medicare 
fraud. Though the number of newly enrolling hospices in Ohio has 
remained fairly steady over the years, we have recently seen, for 
example, instances of numerous hospices operating out of a single 
location. In Georgia, there have been sharp increases in the number of 
hospices there--from 221 in CY 2019 to 273 in CY 2025, or a 24 percent 
rise; in this same timeframe, the number of Medicare beneficiaries 
increased only 6 percent. Again, highly disproportionate and otherwise 
unwarranted increases in hospice enrollments are often indicative of 
fraudulent behavior. The Ohio and Georgia situations were so alarming 
that in 2025 we expanded our four-State PPEO to include these two 
States. With this spread in hospice fraud--combined with the previously 
noted fraud cases in typically lower-risk States such as Oklahoma, 
Utah, and Louisiana--fraudulent hospice activity is clearly a 
nationwide problem, not a regional or local one. It is not limited to 
long-standing hotspots of provider and supplier fraud, waste, and abuse 
such as south Florida. Indeed--like Ohio and Georgia--Nevada, Arizona, 
and even Los Angeles County were never previously deemed as posing 
excessively high hospice fraud risks. All of this shows that hospice 
fraud can (and does) arise anywhere at any time--and can spread to any 
location regardless of that area's perceived historical risk. As we 
stated in a previous HHA moratorium notice: ``The HHS-OIG and CMS have 
learned that some fraud schemes are viral, meaning they replicate 
rapidly within communities, and that health care fraud also migrates--
as law enforcement cracks down on a particular scheme, the criminals 
may redesign the scheme or relocate to a new geographic area.'' \24\ We 
saw instances of this in our prior HHA and non-emergency ambulance 
supplier moratoria. Providers would leave the initial counties that 
were subject to the moratoria and move to other locations to circumvent 
the enrollment ban. While our consequent expansion to State-based 
moratoria alleviated this problem on a county-level, we still saw 
isolated circumvention efforts whereby providers would leave the 
impacted States and enroll new locations elsewhere. With a nationwide 
hospice moratorium, though, prospective hospice enrollees seeking to 
defraud Medicare would have no new geographic area to go to.\25\
---------------------------------------------------------------------------

    \24\ ``Medicare, Medicaid, and Children's Health Insurance 
Programs: Announcement of Temporary Moratoria on Enrollment of 
Ambulances Suppliers and Providers and Home Health Agencies in 
Designated Geographic Areas'', July 31, 2013 (78 FR 46339).
    \25\ California enacted legislation in 2021 (SB-664, Health & 
Safety Code Article 2.3) that placed a moratorium on the issuance of 
new hospice licenses in the State; the moratorium remains in effect. 
Although it has helped to significantly reduce the number of new 
HHAs in California (see Table 2), it cannot prevent hospice 
enrollment in other States, a problem that a nationwide enrollment 
moratorium could resolve.
---------------------------------------------------------------------------

D. Moratorium Determination and Scope

    Considering the foregoing concerns, and after consultation with the 
OIG, CMS has concluded that hospices have a significant potential for 
fraud, waste or abuse. With the need to prevent potential fraud before 
it begins rather than after the fact, we have determined to impose a 
nationwide moratorium on the enrollment of all hospices and hospice 
practice locations. Beginning on the effective date of this notice, no 
new hospices or hospice practice locations will be enrolled in Medicare 
unless the hospice's enrollment application was received by the 
applicable Medicare contractor prior to this notice's effective date. 
Geographically, the moratorium applies to hospices seeking to enroll 
anywhere in the United States, including all States, territories, and 
the District of Columbia.
    Section 424.550(b), as already mentioned, requires a hospice 
undergoing a non-exempt CIMO within 36 months of its initial enrollment 
(or within 36 months of its most recent CIMO) to enroll in Medicare as 
a brand-new hospice and undergo a State survey or accreditation. The 
hospice's current enrollment and provider agreement are terminated. 
This means the hospice's new enrollment is an initial enrollment no 
less than if the hospice had never enrolled in Medicare before. Hence, 
our moratorium will prevent a hospice undergoing a non-exempt CIMO from 
reenrolling in Medicare because, again, it would constitute an initial 
enrollment; the hospice is ``new.''

E. Application to Medicaid and CHIP

    Section 1866(j)(7) of the Act authorizes imposition of a temporary 
enrollment moratorium for Medicare, Medicaid or CHIP if the Secretary 
determines such moratorium is necessary to prevent or combat fraud, 
waste, or abuse under either program. The Secretary is not required to 
impose a particular moratorium on all three programs. This statutory 
discretion enables the Secretary to impose a moratorium on any 
combination of the three programs or one program alone.\26\
---------------------------------------------------------------------------

    \26\ The aforementioned February 2, 2011, final rule also 
established new Medicaid regulations at 42 CFR part 455, subpart E, 
including Sec.  455.470, which implements the moratoria authority 
under section 1902(kk)(4) of the Act. Likewise, that final rule 
implemented Sec.  457.990, providing that part 455, subpart E 
applies to CHIP in the same manner as it applies to Medicaid. Under 
Sec.  455.470(a)(1) through (3), the Secretary may impose a 
temporary moratorium, in accordance with Sec.  424.570, on the 
enrollment of new providers or provider types after consulting with 
any affected State Medicaid agencies. The State Medicaid agency will 
impose a temporary moratorium on the enrollment of new providers or 
provider types identified by the Secretary as posing an increased 
risk to the Medicaid program unless the State determines that the 
imposition of a moratorium would adversely affect Medicaid 
beneficiaries' access to medical assistance and so notifies the 
Secretary in writing.
---------------------------------------------------------------------------

    At this time, we believe it is in Medicaid and CHIP beneficiaries' 
best interest to allow each State to decide whether some form of a 
hospice moratorium is appropriate for their respective Medicaid 
programs and CHIPs, and the scope of any such moratorium. Each State 
has greater expertise and experience with their hospice provider 
types--including the requirements for each type of hospice--than CMS. 
Nevertheless, CMS encourages each State to, as appropriate, implement a 
hospice moratorium tailored to the specifics of their beneficiary 
population as well as any geographic considerations, (in accordance 
with 42 CFR 455.470(b)). CMS is also offering every State and territory 
the opportunity to consult with CMS on the prospect of implementing a 
Medicaid- or CHIP-based (or both) hospice moratorium in their 
jurisdictions.

F. Beneficiary Access to Care

    In general, and excluding the recent increases in Arizona, 
California, Georgia, Nevada, and Texas, the number of enrolled hospices 
nationwide has remained reasonably stable over the past 7 years. During 
this period, we saw little evidence of nationwide, across-the-board 
hospice access-to-care issues for beneficiaries in Medicare--or, for 
that matter, in Medicaid or CHIP. Therefore, we do not believe that a 
national moratorium will threaten beneficiaries' ability to receive 
hospice services in any of these programs. However, we will monitor for 
any access to care issues.

III. No Judicial Review of CMS's Decision To Impose an Enrollment 
Moratorium

    In accordance with section 1866(j)(7)(B) of the Act, there is no 
judicial review under sections 1869 and 1878 of the Act, or otherwise, 
of the

[[Page 27953]]

decision to impose a temporary enrollment moratorium. Under Sec. Sec.  
424.530(a)(10) and 424.570(c), CMS denies the enrollment application of 
a provider or supplier if the provider or supplier is subject to a 
moratorium. In addition, Sec.  424.514(d)(2)(v)(C) states that if the 
provider or supplier was required to pay an application fee, the 
application fee will be refunded if the application was denied because 
of the imposition of a temporary moratorium. However, a provider or 
supplier that is impacted by a moratorium may use the existing appeal 
procedures at 42 CFR part 498 to administratively appeal a denial of 
billing privileges based on the imposition of a temporary moratorium; 
the scope of any such appeal, though, would be limited solely to 
assessing whether the temporary moratorium applies to the provider or 
supplier appealing the denial. (See 42 CFR 498.5(l)(4)).

IV. Collection of Information Requirements

    This document does not impose information collection and 
recordkeeping requirements. Consequently, it need not be reviewed by 
the Office of Management and Budget under the authority of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520).

V. Regulatory Impact Statement

A. Statement of Need

    This notice is necessary to help reduce the prevalence of Medicare 
fraud, waste, and abuse among hospices.

B. Overall Impact

    We have examined the impacts of this notice as required by E.O. 
12866, ``Regulatory Planning and Review''; E.O. 13132, ``Federalism; E. 
O. 13563, ``Improving Regulation and Regulatory Review''; E.O. 14192, 
``Unleashing Prosperity Through Deregulation''; the Regulatory 
Flexibility Act (RFA), 5 U.S.C. 601 through 612; section 1102(b) of the 
Social Security Act; and section 202 of the Unfunded Mandates Reform 
Act of 1995.
    Executive Orders 12866 and 13563 direct agencies to assess all 
costs and benefits of available regulatory alternatives and, if 
regulation is necessary, to select those regulatory approaches that 
maximize net benefits (including potential economic, environmental, 
public health and safety, and other advantages; and distributive 
impacts). Based on our analysis, the Office of Information and 
Regulatory Affairs (OIRA) has determined that this notice is not 
significant pursuant to section 3(f)(1) of Executive Order 12866. In 
accordance with the provisions of Executive Order 12866, this notice 
was reviewed by the Office of Management and Budget. In accordance with 
Subtitle E of the Small Business Regulatory Enforcement Fairness Act of 
1996 (also known as the Congressional Review Act), OIRA has also 
determined that this notice does not meet the criteria for a major rule 
as defined in 5 U.S.C. 804(2).
    In addition, section 1102(b) of the Act requires us to prepare a 
regulatory impact analysis if a rule may have a significant impact on 
the operations of a substantial number of small rural hospitals. This 
analysis must conform to the RFA provisions at 5 U.S.C. 604. For 
purposes of section 1102(b) of the Act, we define a small rural 
hospital as a hospital that is located outside of a metropolitan 
statistical area and has fewer than 100 beds. This notice is primarily 
applicable to hospices, not rural hospitals. Therefore, the Secretary 
has certified that this notice will not have a significant economic 
impact on the operations of small rural hospitals.
    We expect savings to the Medicare program from the reduction in the 
number of newly enrolling hospices. However, we do not have data upon 
which to base an estimate of the amount of savings.

C. Regulatory Flexibility Analysis (RFA)

1. Small Business Impact
    The RFA requires agencies to analyze options for regulatory relief 
of small businesses. For purposes of the RFA, small entities include 
small businesses, nonprofit organization, and small governmental 
jurisdictions. Most entities and most other providers and suppliers are 
small entities, either by nonprofit status or by having revenues less 
than $19 million to $41 million in any 1 year. Individuals and States 
are not included in the definition of a small entity. We do not believe 
that this hospice moratorium notice will have a significant economic 
impact on a substantial number of small businesses. Excluding the 
aforementioned outliers in Arizona, California, Georgia, Nevada, and 
Texas, between CY 2023 and CY 2025 the combined nationwide number of 
new enrollments was roughly 500 (166 per year). If we assumed that a 
similar number would seek to enroll during the moratorium would be 
prohibited from doing so, this is a miniscule percentage when compared 
to the well over 2 million providers and suppliers currently enrolled 
in Medicare; the same would hold true if several hundred hospice 
practice locations (aside from the main provider) could not be added by 
hospice providers. Furthermore--aside from their ability to add new 
practice locations to their enrollments--the moratorium would not 
impact the approximately 7,000 currently enrolled hospices, which could 
continue furnishing services (assuming they remain complaint with all 
Medicare requirements). Accordingly, very few small businesses will be 
affected by the moratorium. Even conceding the impact on newly 
enrolling hospices and prospective hospice practice locations, we 
believe that the risk that hospice fraud, waste, and abuse poses to the 
Trust Funds, Medicare beneficiaries, and the taxpayers far exceeds this 
and thus justifies our measure.
2. Alternatives Considered
    There are two principal alternatives we considered in preparing 
this notice. First, we considered forgoing a moratorium entirely. Yet 
as already noted, the longstanding fraud, waste, and abuse problems 
require remedial measures beyond those we presently utilize. Helpful 
though the latter have been, more is needed. Second, we contemplated 
limiting the moratorium to the six States currently subject to the 
previously-mentioned hospice PPEO. However, we reiterate that the 
problems the moratorium seeks to address are nationwide instead of 
restricted to particular geographic areas. As we also stated earlier, 
the transient nature of fraud schemes--as shown in, for instance, the 
sudden upswing in new hospices in States like Nevada and Georgia--
require nationwide proactivity to prevent these schemes from developing 
in the first place. Third, we contemplated requiring States to 
implement a hospice moratorium, but, as noted, we believe States are in 
the best position to determine whether a moratorium is appropriate for 
their jurisdictions and beneficiary populations.

D. Unfunded Mandates Reform Act (UMRA)

    Section 202 of UMRA of 1995 UMRA also requires that agencies assess 
anticipated costs and benefits before issuing any rule whose mandates 
require spending in any 1 year of $100 million in 1995 dollars, updated 
annually for inflation. In 2026, that threshold is approximately $193 
million. This notice will not impose a mandate that will result in the 
expenditure by State, local, and Tribal governments, in the aggregate, 
or by the private sector, of more than $193 million in any 1 year. UMRA 
only applies in situations where an agency

[[Page 27954]]

engages in notice-and-comment rulemaking. It does not apply to this 
notice.

E. State and Local Costs

    Executive Order 13132 establishes certain requirements that an 
agency must meet when it promulgates a proposed regulatory action (and 
subsequent final action) that imposes substantial direct requirement 
costs on State and local governments, preempts State law, or otherwise 
has Federalism implications. Since this notice does not impose any 
costs on State or local governments, the requirements of Executive 
Order 13132 are not applicable.
    The Administrator of the Centers for Medicare & Medicaid Services 
(CMS), Dr. Mehmet Oz, having reviewed and approved this document, 
authorizes Chyana Woodyard, who is the Federal Register Liaison, to 
electronically sign this document for purposes of publication in the 
Federal Register.

Chyana Woodyard,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2026-09718 Filed 5-13-26; 8:45 am]
BILLING CODE 4120-01-P